Department of Radiopharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
J Drug Target. 2012 Jun;20(5):401-15. doi: 10.3109/1061186X.2012.685477. Epub 2012 May 4.
Molecular imaging is a relatively new discipline with a crucial role in diagnosis and treatment tracing of diseases through characterization and quantification of biological processes at cellular and sub-cellular levels of living organisms. These molecular targeted systems can be conjugated with contrast agents or radioligands to obtain specific molecular probes for the purpose of diagnosis of diseases more accurately by different imaging modalities. Nowadays, an interesting new approach to molecular imaging is the use of stealth nanosized drug delivery systems such as liposomes having convenient properties such as biodegradability, biocompatibility and non-toxicity and they can specifically be targeted to desired disease tissues by combining with specific targeting ligands and probes. The targeted liposomes as molecular probes in molecular imaging have been evaluated in this review. Therefore, the essential point is detection of molecular target of the disease which is different from normal conditions such as increase or decrease of a receptor, transporter, hormone, enzyme etc, or formation of a novel target. Transport of the diagnostic probe specifically to targeted cellular, sub-cellular or even to molecular entities can be performed by molecular imaging probes. This may lead to produce personalized medicine for imaging and/or therapy of diseases at earlier stages.
分子成像是一门相对较新的学科,通过对活生物体细胞和亚细胞水平的生物过程进行特征描述和定量,在疾病的诊断和治疗追踪方面发挥着关键作用。这些分子靶向系统可以与对比剂或放射性配体结合,获得特定的分子探针,以便通过不同的成像方式更准确地诊断疾病。如今,分子成像的一个有趣的新方法是使用具有生物降解性、生物相容性和低毒性等便利特性的隐形纳米药物递送系统,如脂质体,并通过与特定的靶向配体和探针结合,将其特异性靶向到所需的疾病组织。本综述评估了靶向脂质体作为分子成像中的分子探针。因此,关键是检测疾病的分子靶点,这些靶点与正常情况不同,例如受体、转运蛋白、激素、酶等的增加或减少,或者形成新的靶点。通过分子成像探针可以将诊断探针特异性地输送到靶向细胞、亚细胞甚至分子实体。这可能导致更早阶段对疾病进行成像和/或治疗的个体化药物的产生。